ArticleFrontiers in oncology2021

The circRAB3IP Mediated by eIF4A3 and LEF1 Contributes to Enzalutamide Resistance in Prostate Cancer by Targeting miR-133a-3p/miR-133b/SGK1 Pathway.

Dong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.